• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素化与去泛素化在非酒精性脂肪性肝病发病机制中的作用

The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver disease.

作者信息

Zhang Lihui, Liu Sutong, Zhao Qing, Liu Xiaoyan, Zhang Qiang, Liu Minghao, Zhao Wenxiao

机构信息

The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine, Zhengzhou, Henan, China.

出版信息

Front Immunol. 2025 Apr 11;16:1535362. doi: 10.3389/fimmu.2025.1535362. eCollection 2025.

DOI:10.3389/fimmu.2025.1535362
PMID:40292292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12021615/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases and is closely associated with metabolic abnormalities. The causes of NAFLD are exceedingly complicated, and it is known that a variety of signaling pathways, endoplasmic reticulum stress, and mitochondrial dysfunction play a role in the pathogenesis of NAFLD. Recent studies have shown that ubiquitination and deubiquitination are involved in the regulation of the NAFLD pathophysiology. Protein ubiquitination is a dynamic and diverse post-translational alteration that affects various cellular biological processes. Numerous disorders, including NAFLD, exhibit imbalances in ubiquitination and deubiquitination. To highlight the significance of this post-translational modification in the pathogenesis of NAFLD and to aid in the development of new therapeutic approaches for the disease, we will discuss the role of enzymes involved in the processes of ubiquitination and deubiquitination, specifically E3 ubiquitin ligases and deubiquitinating enzymes that are important in the regulation of NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病之一,与代谢异常密切相关。NAFLD的病因极其复杂,已知多种信号通路、内质网应激和线粒体功能障碍在NAFLD的发病机制中起作用。最近的研究表明,泛素化和去泛素化参与了NAFLD病理生理学的调节。蛋白质泛素化是一种动态且多样的翻译后修饰,影响各种细胞生物学过程。包括NAFLD在内的许多疾病都表现出泛素化和去泛素化的失衡。为了突出这种翻译后修饰在NAFLD发病机制中的重要性,并有助于开发该疾病的新治疗方法,我们将讨论参与泛素化和去泛素化过程的酶的作用,特别是在NAFLD调节中起重要作用的E3泛素连接酶和去泛素化酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/7fd0fca5e904/fimmu-16-1535362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/7d37e0066994/fimmu-16-1535362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/ebcc9d1445f0/fimmu-16-1535362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/5717c5c6ac5f/fimmu-16-1535362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/7fd0fca5e904/fimmu-16-1535362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/7d37e0066994/fimmu-16-1535362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/ebcc9d1445f0/fimmu-16-1535362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/5717c5c6ac5f/fimmu-16-1535362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd4/12021615/7fd0fca5e904/fimmu-16-1535362-g004.jpg

相似文献

1
The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver disease.泛素化与去泛素化在非酒精性脂肪性肝病发病机制中的作用
Front Immunol. 2025 Apr 11;16:1535362. doi: 10.3389/fimmu.2025.1535362. eCollection 2025.
2
The role and advance of ubiquitination and deubiquitination in depression pathogenesis and treatment.泛素化和去泛素化在抑郁症发病机制和治疗中的作用和进展。
Drug Dev Res. 2024 Nov;85(7):e70005. doi: 10.1002/ddr.70005.
3
The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?E3 泛素连接酶和去泛素化酶在炎症性肠病中的作用:是敌是友?
Front Immunol. 2021 Dec 8;12:769167. doi: 10.3389/fimmu.2021.769167. eCollection 2021.
4
Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression.阐明泛素化和去泛素化在骨关节炎进展中的作用。
Front Immunol. 2023 Jun 9;14:1217466. doi: 10.3389/fimmu.2023.1217466. eCollection 2023.
5
Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的器官间代谢相互作用网络。
Front Endocrinol (Lausanne). 2025 Jan 9;15:1494560. doi: 10.3389/fendo.2024.1494560. eCollection 2024.
6
OTUD7B inhibited hepatic injury from NAFLD by inhibiting K48-linked ubiquitination and degradation of β-catenin.OTUD7B 通过抑制 β-连环蛋白的 K48 连接泛素化和降解来抑制 NAFLD 引起的肝损伤。
Biochim Biophys Acta Mol Basis Dis. 2025 Jan;1871(1):167555. doi: 10.1016/j.bbadis.2024.167555. Epub 2024 Nov 8.
7
Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.RNF186 介导的细胞质 HMGB1 泛素化调控非酒精性脂肪性肝病的肝脂噬作用。
Metabolism. 2024 Mar;152:155769. doi: 10.1016/j.metabol.2023.155769. Epub 2023 Dec 27.
8
Novel insights into the role of ubiquitination in osteoarthritis.泛素化在骨关节炎中的作用的新见解。
Int Immunopharmacol. 2024 May 10;132:112026. doi: 10.1016/j.intimp.2024.112026. Epub 2024 Apr 8.
9
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11.通过抑制去泛素化酶 RPN11 改善非酒精性脂肪性肝病。
Cell Metab. 2024 Oct 1;36(10):2228-2244.e7. doi: 10.1016/j.cmet.2024.07.014. Epub 2024 Aug 14.
10
Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.内质网应激与自噬在非酒精性脂肪性肝病(NAFLD)发病机制中的作用:现有证据和观点。
Curr Obes Rep. 2021 Jun;10(2):134-161. doi: 10.1007/s13679-021-00431-3. Epub 2021 Mar 22.

本文引用的文献

1
ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis.ZDHHC20介导的脂肪酸合酶(FASN)的S-棕榈酰化促进肝癌发生。
Mol Cancer. 2024 Dec 19;23(1):274. doi: 10.1186/s12943-024-02195-5.
2
The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy.肿瘤免疫微环境中的泛素-蛋白酶体系统:联合治疗的关键力量。
Front Immunol. 2024 Sep 9;15:1436174. doi: 10.3389/fimmu.2024.1436174. eCollection 2024.
3
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11.
通过抑制去泛素化酶 RPN11 改善非酒精性脂肪性肝病。
Cell Metab. 2024 Oct 1;36(10):2228-2244.e7. doi: 10.1016/j.cmet.2024.07.014. Epub 2024 Aug 14.
4
Inhibiting TRIM8 alleviates adipocyte inflammation and insulin resistance by regulating the DUSP14/MAPKs pathway.抑制 TRIM8 通过调节 DUSP14/MAPKs 通路减轻脂肪细胞炎症和胰岛素抵抗。
Adipocyte. 2024 Dec;13(1):2381262. doi: 10.1080/21623945.2024.2381262. Epub 2024 Jul 22.
5
Variety in the USP deubiquitinase catalytic mechanism.USP 去泛素化酶催化机制的多样性。
Life Sci Alliance. 2024 Feb 14;7(4). doi: 10.26508/lsa.202302533. Print 2024 Apr.
6
Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer.AKT2 激活促进 SREBP1/SCD1 介导的脂质代谢增强肝脂肪变性和癌症。
Transl Res. 2024 Jun;268:51-62. doi: 10.1016/j.trsl.2024.01.005. Epub 2024 Jan 18.
7
TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.TRIB3-TRIM8 复合物通过调节 HNF4α 的稳定性来驱动非酒精性脂肪性肝病的进展。
J Hepatol. 2024 May;80(5):778-791. doi: 10.1016/j.jhep.2023.12.029. Epub 2024 Jan 17.
8
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase.TRIM56 通过促进脂肪酸合酶的降解来预防非酒精性脂肪性肝病。
J Clin Invest. 2024 Jan 11;134(5):e166149. doi: 10.1172/JCI166149.
9
Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.RNF186 介导的细胞质 HMGB1 泛素化调控非酒精性脂肪性肝病的肝脂噬作用。
Metabolism. 2024 Mar;152:155769. doi: 10.1016/j.metabol.2023.155769. Epub 2023 Dec 27.
10
UFMylation: a ubiquitin-like modification.泛素化修饰:一种类泛素修饰。
Trends Biochem Sci. 2024 Jan;49(1):52-67. doi: 10.1016/j.tibs.2023.10.004. Epub 2023 Nov 7.